Burden of Clostridium difficile Infection in the United States

Cited by (1,002)

Items 701–800 of 1,002

1. Clostridium difficile
   Scott R. Curry · 2017 · Clinics in Laboratory Medicine
2. Potential Probiotic Strains From Milk and Water Kefir Grains in Singapore—Use for Defense Against Enteric Bacterial Pathogens
   Li Ling Tan, Chuan Hao Tan, Noele Kai Jing Ng, Yoke Hun Tan, Patricia L. Conway, Say Chye Joachim Loo · 2022 · Frontiers in Microbiology
3. Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants
   Songhai Tian, Xiaozhe Xiong, Ji Zeng, Siyu Wang, Benjamin J.-M. Tremblay, Peng Chen, Baohua Chen, Min Liu, Pengsheng Chen, Kuanwei Sheng et al. · 2022 · Nature Communications
4. Superbugs versus Outsourced Cleaners
   Adam Seth Litwin, Ariel Chanan Avgar, Edmund R. Becker · 2016 · Industrial and Labor Relations Review
5. Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults
   Krishna K. Rao, Kavitha Santhosh, Jill A. Mogle, Peter Higgins, Vincent Bensan Young · 2016 · Scandinavian Journal of Infectious Diseases
6. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong
   Sunny Hei Wong, Margaret Ip, Peter Michael Hawkey, Norman Wai Sing Lo, Katie Hardy, Susan E Manzoor, Wyman W.M. Hui, Kin‐Wing Choi, Rity Y. K. Wong, Irene M.H. Yung et al. · 2016 · Journal of Infection
7. Reducing Recurrence of C. difficile Infection
   Michael G. Dieterle, Vincent Bensan Young · 2017 · Cell
8. Revisiting the Role of Csp Family Proteins in Regulating Clostridium difficile Spore Germination
   Yuzo L. Kevorkian, Aimee Shen · 2017 · Journal of Bacteriology
9. Effect of Bifidobacterium breve in Combination With Different Antibiotics on Clostridium difficile
   Jingpeng Yang, Hong Yang · 2018 · Frontiers in Microbiology
10. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial
    Louise Thorlacius-Ussing, Christian Østergaard Andersen, Jens Kjølseth Møller, Inge Jenny Dahl Knudsen, Jens Dilling Lundgren, Thomas Benfield · 2019 · Trials
11. Pitfalls in Diagnosis of Pediatric Clostridium difficile Infection
    Julia Shaklee Sammons, Philip Toltzis · 2015 · Infectious Disease Clinics of North America
12. Insights From the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients
    James B. Wetmore, Suying Li, Julia T. Molony, Haifeng Guo, Charles A. Herzog, David T. Gilbertson, Yi Peng, Allan J. Collins · 2017 · American Journal of Kidney Diseases
13. Reductions in Clostridium difficile Infection (CDI) Rates Using Real-Time Automated Clinical Criteria Verification to Enforce Appropriate Testing
    Kathleen A. Quan, Jennifer Yim, Doug Merrill, Usme Khusbu, Keith M. Madey, Linda L. Dickey, Amish Ajit Dangodara, Scott Rudkin, Margaret O’Brien, Daniel Thompson et al. · 2018 · Infection Control and Hospital Epidemiology
14. Epidemiology and outcomes of Clostridium difficile infection among hospitalised patients: results of a multicentre retrospective study in South Africa
    Laurel M. Legenza, Susanne G. Barnett, Warren E. Rose, Monica L. Bianchini, Nasia Safdar, Renier Coetzee · 2018 · BMJ Global Health
15. Oral vancomycin prophylaxis during systemic antibiotic exposure to preventClostridiodes difficileinfection relapses
    Daniel A. Caroff, John Thomas Menchaca, Zilu Zhang, Chanu Rhee, Michael S. Calderwood, David W. Kubiak, Deborah S. Yokoe, Michael Klompas · 2019 · Infection Control and Hospital Epidemiology
16. Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection
    Ashley Dawn Smith, Elissa D. Foss, Irma Zhang, Jessica L. Hastie, Nicole P. Giordano, Lusine Gasparyan, Lam Phuc VinhNguyen, Alyxandria M. Schubert, Deepika Prasad, Hannah L. McMichael et al. · 2019 · PLoS ONE
17. Synthetic Oligosaccharide-Based Vaccines Protect Mice from Clostridioides difficile Infections
    Felix Broecker, Erik Wegner, Bruna M. S. Seco, Paulina Kapłonek, Maria Bräutigam, Armin Ensser, Frederick Pfister, Christoph Daniel, Christopher E. Martin, Jochen Mattner et al. · 2019 · ACS Chemical Biology
18. The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis
    Terry W. Bilverstone, Megan Garland, Rory J. Cave, Michelle L. Kelly, Martina Tholen, Donna M. Bouley, Philip Kaye, Nigel Peter Minton, Matthew S. Bogyo, Sarah A. Kuehne et al. · 2020 · PLoS Pathogens
19. A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor
    Michaella J. Whittle, Terry W. Bilverstone, R. J. van Esveld, Arlen-Celina Lücke, Michelle M. Lister, Sarah A. Kuehne, Nigel Peter Minton · 2022 · Microbiology Spectrum
20. The Epidemiology and Clinical Features of Clostridium difficile Infection in Liver Transplant Recipients
    Timothy Sullivan, Alan D. Weinberg, Meenakshi M. Rana, Gopi Patel, Shirish S. Huprikar · 2016 · Transplantation
21. Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment
    Ying Margie Tang, Christian D. Stone · 2017 · Clinical Journal of Gastroenterology
22. Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France
    Maureen Watt, Aurélien Dinh, Alban Le Monnier, Patrick R. Tilleul · 2017 · Journal of Medical Economics
23. Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease
    Anna Maria Seekatz, Emily Wolfrum, Christopher M. DeWald, Rosemary K.B. Putler, Kimberly C. Vendrov, Krishna K. Rao, Vincent Bensan Young · 2018 · Anaerobe
24. Clostridium difficile colitis and zoonotic origins—a narrative review
    Alexander Brown, Robert Beaumont Wilson · 2018 · Gastroenterology report
25. Neutralization of macrophage migration inhibitory factor improves host survival after Clostridium difficile infection
    Shinsmon Jose, Anindita Mukherjee, Mayuresh M. Abhyankar, Lin Leng, Richard Bucala, Divya Sharma, Rajat Madan · 2018 · Anaerobe
26. Effectiveness of ultraviolet disinfection in reducing hospital-acquired Clostridium difficile and vancomycin-resistant Enterococcus on a bone marrow transplant unit
    Jennifer Brite, Tracy A. McMillen, Elizabeth V. Robilotti, Janet Y. Sun, Hoi Yan Chow, Frederic Stell, Susan K. Seo, Donna F. McKenna, Janet A. Eagan, Marisa A. Montecalvo et al. · 2018 · Infection Control and Hospital Epidemiology
27. The epidemiology of Clostridioides difficile infection in Brazil: A systematic review covering thirty years
    Camilla Nunes Dos Reis Trindade, Regina Maria Cavalcanti Pilotto Domingues, Eliane de Oliveira Ferreira · 2019 · Anaerobe
28. Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere Clostridioides difficile Infections
    Jianyi Yin, Larry K. Kociolek, Rebecca G Same, Alice Jenh Hsu, Joe Amoah, Pranita D. Tamma · 2019 · Open Forum Infectious Diseases
29. Antimicrobial resistance in Clostridium difficile ribotype 017
    Korakrit Imwattana, Daniel R. Knight, Brian Kullin, Deirdre A. Collins, Papanin Putsathit, Pattarachai Kiratisin, Thomas Victor Riley · 2019 · Expert Review of Anti-infective Therapy
30. Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management
    Mei Bai, Hong Guo, Xiao-Yao Zheng · 2023 · Therapeutic Advances in Gastroenterology
31. A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions
    Natasha Nanwa, Beate Sander, Murray Dale Krahn, Nick Daneman, Hong Lu, Peter C. Austin, Anand Govindarajan, Laura C. Rosella, Suzanne M. Cadarette, Jeffrey C. Kwong · 2017 · PLoS ONE
32. Incidence, Risk Factors, and Impact of Clostridium difficile Colitis After Spine Surgery
    Patawut Bovonratwet, Daniel D. Bohl, Glenn S. Russo, Nathaniel T. Ondeck, Kern Singh, Jonathan Newman Grauer · 2017 · Spine
33. Molecular epidemiology of Clostridium difficile in two tertiary care hospitals in Shandong Province, China
    Ying Luo, Wen Zhang, Jing-Wei Cheng, Meng Xiao, Gui-Rong Sun, Cheng-Jie Guo, Ming-Jun Liu, Cong PS, Timothy Kudinha · 2018 · Infection and Drug Resistance
34. Clindamycin, Gentamicin, and Risk of Clostridium difficile Infection and Acute Kidney Injury During Delivery Hospitalizations
    Cassandra R. Duffy, Yongmei Huang, Maria Andrikopoulou, Conrad N. Stern-Ascher, Jason Dennis Wright, Dena Goffman, Mary E. D’Alton, Alexander Michael Friedman · 2019 · Obstetrics and Gynecology
35. From Nursery to Nursing Home: Emerging Concepts in Clostridioides difficile Pathogenesis
    Alexander B. Smith, Joshua Soto Ocaña, Joseph P. Zackular · 2020 · Infection and Immunity
36. Molecular basis for catabolism of the abundant metabolite trans-4-hydroxy-L-proline by a microbial glycyl radical enzyme
    Lindsey R. F. Backman, Yolanda Y. Huang, Mary C. Andorfer, Brian Gold, Ronald T. Raines, Emily P. Balskus, Catherine Luschinsky Drennan · 2020 · eLife
37. Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study
    Brittany Stephenson, Cristina Lanzas, Suzanne Lenhart, Eduardo Cesar Lazcano-Ponce, Jason Bintz, Erik R. Dubberke, Judy Day · 2020 · BMC Infectious Diseases
38. Lower endoscopic delivery of freeze-dried intestinal microbiota results in more rapid and efficient engraftment than oral administration
    Christopher M. Staley, Hossam Halaweish, Carolyn T. Graiziger, Matthew J. Hamilton, Amanda J. Kabage, Alison L. Galdys, Byron P. Vaughn, Kornpong Vantanasiri, Raj Suryanarayanan, Michael Jay Sadowsky et al. · 2021 · Scientific Reports
39. Predictive regulatory and metabolic network models for systems analysis of Clostridioides difficile
    Mario L. Arrieta‐Ortiz, Selva Rupa Christinal Immanuel, Serdar Turkarslan, Wei‐Ju Wu, Brintha Parasumanna Girinathan, Jay Noboru Worley, Nicholas DiBenedetto, Olga A. Soutourina, Peltier Johann, Bruno Dupuy et al. · 2021 · Cell Host & Microbe
40. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study
    Xin Wen, Cong Shen, Jinyu Xia, Lan‐Lan Zhong, Zhongwen Wu, Mohamed Abd El-Gawad El-Sayed Ahmed, Nana Long, Furong Ma, Guili Zhang, Wenwei Wu et al. · 2022 · Microbiology Spectrum
41. Host Immunity and Immunization Strategies for Clostridioides difficile Infection
    Farha Naz, William A. Petri · 2023 · Clinical Microbiology Reviews
42. Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A
    Carrie A. Cowardin, Brianna Marie Jackman, Zannatun Noor, Stacey L. Burgess, Andrew L. Feig, William A. Petri · 2016 · Infection and Immunity
43. Evaluating the Risk Factors for Hospital-Onset Clostridium difficile Infections in a Large Healthcare System
    Troy Watson, Jason D. Hickok, Sarah Fraker, Kimberly M. Korwek, Russell E Poland, Edward Joel Septimus · 2017 · Clinical Infectious Diseases
44. Diagnosis of Clostridium difficile infection using an UPLC–MS based metabolomics method
    Pengcheng Zhou, Ning Zhou, Li Shao, ­Jun Li­, Sidi Liu, Xiujuan Meng, Juping Duan, Xinrui Xiong, Xun Huang, Yuhua Chen et al. · 2018 · Metabolomics
45. Unravelling the Links between Phage Adsorption and Successful Infection in Clostridium difficile
    Anisha M. Thanki, Grace Taylor-Joyce, Ahmed S. A. Dowah, Janet Yakubu Nale, Danish J. Malik, Martha R. J. Clokie · 2018 · Viruses
46. Local outbreak of Clostridioides difficile PCR-Ribotype 018 investigated by multi locus variable number tandem repeat analysis, whole genome multi locus sequence typing and core genome single nucleotide polymorphism typing
    Cécile Gateau, Stéphanie Deboscker, Jeanne Couturier, Thomas Vogel, Elise Schmitt, Joris Muller, Céline Ménard, Béatrice Turcan, Rabab Syed-Zaidi, Anlyata Youssouf et al. · 2019 · Anaerobe
47. Bugs and Guts
    Danielle M. Barnes, Ann Ming Yeh · 2015 · Nutrition in Clinical Practice
48. Vaccines for Healthcare-associated Infections: Promise and Challenge
    Jane M. Knisely, Baoying Liu, Ryan T. Ranallo, Lanling Zou · 2016 · Clinical Infectious Diseases
49. Community- and Healthcare-AssociatedClostridium difficileInfections, Finland, 2008−20131
    Saara Kotila, Silja Mentula, Jukka P. Ollgren, Anni Virolainen-Julkunen, Outi Lyytikäinen · 2016 · Emerging infectious diseases
50. Variation in US outpatient antibiotic prescribing quality measures according to health plan and geography.
    Rebecca M. Roberts, Lauri A. Hicks, Monina G. Bartoces · 2016 · PubMed
51. Characterization of Clostridium difficile PCR-ribotype 018: A problematic emerging type
    Fabrizio Barbanti, Patrizia Spigaglia · 2016 · Anaerobe
52. Disease Burden ofClostridium difficileInfections in Adults, Hong Kong, China, 2006–2014
    Jeffery Ho, Rudin Z.W. Dai, Thomas N.Y. Kwong, Xiansong Wang, Lin Zhang, Margaret Ip, Raphael C.Y. Chan, Peter Michael Hawkey, Kelvin Long‐Yan Lam, Martin C. S. Wong et al. · 2017 · Emerging infectious diseases
53. An Observational Cohort Study of Clostridium difficile Ribotype 027 and Recurrent Infection
    Krishna K. Rao, Peter Higgins, Vincent Bensan Young · 2018 · mSphere
54. Ridinilazole: a novel antimicrobial for Clostridium difficile infection
    Jonathan C. Cho · 2018 · Annals of Gastroenterology
55. Enterotoxic Clostridia:Clostridioides difficileInfections
    Steven J. Mileto, A. Das, Dena Lyras · 2019 · Microbiology Spectrum
56. Implementation of a Clostridioides difficile prevention bundle: Understanding common, unique, and conflicting work system barriers and facilitators for subprocess design
    Jackson Musuuza, Ann Schoofs Hundt, Pascale Carayon, Karly Christensen, Caitlyn R. Ngam, Nicholas Haun, Nasia Safdar · 2019 · Infection Control and Hospital Epidemiology
57. Structural elucidation of the Clostridioides difficile transferase toxin reveals a single-site binding mode for the enzyme
    Michael J. Sheedlo, David M. Anderson, Audrey K. Thomas, Dana Borden Lacy · 2020 · Proceedings of the National Academy of Sciences
58. Clostridioides difficile proline fermentation in response to commensal clostridia
    Christopher A. Lopez, Tess P. McNeely, Kamila Nurmakova, William N. Beavers, Eric Patrick Skaar · 2020 · Anaerobe
59. Ribotype Classification of Clostridioides difficile Isolates Is Not Predictive of the Amino Acid Sequence Diversity of the Toxin Virulence Factors TcdA and TcdB
    Zheng-Hui Li, Kwok Lee, Urvi Rajyaguru, C. Hal Jones, Sandra Janežič, Maja Rupnik, Annaliesa S. Anderson, Paul Liberator · 2020 · Frontiers in Microbiology
60. Whole genome sequencing of Clostridioides difficile PCR ribotype 046 suggests transmission between pigs and humans
    Anders Werner, Paula Mölling, Anna Fagerström, Fredrik Dyrkell, Dimitrios Arnellos, Karin Johansson, Martin Sundqvist, Torbjörn Norén · 2020 · PLoS ONE
61. Clostridioides difficile Infection, Still a Long Way to Go
    Eleftheria Kampouri, Antony Croxatto, Guy Prod’hom, Benoit P. Guery · 2021 · Journal of Clinical Medicine
62. How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
    Masoumeh Azimirad, Maryam Noori, Hamideh Raeisi, Abbas Yadegar, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Enrico Bentivegna, Paolo Martelletti, Nicola Petrosillo, Mohammad Reza Zali · 2021 · Frontiers in Medicine
63. Diagnostics and treatment of Clostridium difficile-associated disease: Guidelines of the Russian gastroenterological association
    Vladimir T Ivashkin, N.D. Yushchuk, I. V. Mayev, Tatiana L. Lapina, Ye. A. Poluektova, Oleg S. Shifrin, A.S. Tertychny, А. С. Трухманов, Arkadiy A. Sheptulin, Ye. K. Baranskaya et al. · 2016 · Russian Journal of Gastroenterology Hepatology Coloproctology
64. A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease
    Xi-Yue Tan, Yu-Jia Xie, Xinglong Liu, Xinyun Li, Bo Jia · 2022 · Evidence-based Complementary and Alternative Medicine
65. Increased intestinal permeability and downregulation of absorptive ion transporters Nhe3 , Dra , and Sglt1 contribute to diarrhea during Clostridioides difficile infection
    F. Christopher Peritore‐Galve, Izumi Kaji, Anna Smith, Lauren M. Walker, John A. Shupe, Mary Kay Washington, Holly M. Scott Algood, Pradeep Kumar Dudeja, James R. Goldenring, Dana Borden Lacy · 2023 · Gut Microbes
66. Epidemiology of Clostridium difficile infections in Australia: enhanced surveillance to evaluate time trends and severity of illness in Victoria, 2010–2014
    Leon James Worth, Tim D. Spelman, Ann L. Bull, Judith Brett, Michael J. Richards · 2016 · Journal of Hospital Infection
67. Risk factors for Clostridium difficile infection in hemato-oncological patients: A case control study in 144 patients
    Thorsten Fuereder, Danjel Koni, Andreas Gleiß, Michael Kundi, Athanasios Makristathis, Christoph Carl Zielinski, Christoph Steininger · 2016 · Scientific Reports
68. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy
    Esther van Kleef, Sarah R Deeny, Mark Jit, B. Cookson, Simon D. Goldenberg, W. John Edmunds, Julie V. Robotham · 2016 · Vaccine
69. Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort
    Martha L. Carvour, Shane Wilder, Keenan Levy Ryan, Carla J. Walraven, Fares Qeadan, Meghan Brett, Kimberly Ann Page · 2018 · American Journal of Infection Control
70. Suppressive effect ofLactobacillus fermentumLim2 onClostridioides difficile027 toxin production
    Cheng Chung Yong, Jeong‐Hoon Lim, Bum‐Keun Kim, Dong‐June Park, Sejong Oh · 2019 · Letters in Applied Microbiology
71. Quantifying bacterial spore germination by single-cell impedance cytometry for assessment of host microbiota susceptibility to Clostridioides difficile infection
    John H. Moore, Armita Salahi, Carlos Honrado, Christopher J. Warburton, Cirle Alcantara Warren, Nathan S. Swami · 2020 · Biosensors and Bioelectronics
72. Colorectal Cancer in Inflammatory Bowel Disease: A Review of the Role of Gut Microbiota and Bacterial Biofilms in Disease Pathogenesis
    David A. Muñiz Pedrogo, Cynthia L. Sears, Joanna Melia · 2024 · Journal of Crohn s and Colitis
73. Increasing prevalence of the epidemic ribotype 106 in healthcare facility–associated and community-associated Clostridioides difficile infection
    Loreto Suárez-Bode, Rubén Barrón, José Luis Pérez, A. Mena · 2018 · Anaerobe
74. Carriage and colonization of C. difficile in preterm neonates: A longitudinal prospective study
    Laurent Ferraris, Jeanne Couturier, Catherine Eckert, Johanne Delannoy, Frédéric Barbut, Marie‐José Butel, Julio Aires · 2019 · PLoS ONE
75. Regional differences in temporal incidence of Clostridium difficile infection: a systematic review and meta-analysis
    Jeffery Ho, Sunny Hei Wong, Vijaya C. Doddangoudar, Maureen Valerie Boost, Gary Tse, Margaret Ip · 2019 · American Journal of Infection Control
76. Where Stool is a Drug: International Approaches to Regulating the use of Fecal Microbiota for Transplantation
    Alexandra Scheeler · 2019 · The Journal of Law Medicine & Ethics
77. Clostridioides difficile in national food surveillance, Slovenia, 2015 to 2017
    Valerija Tkalec, Urška Jamnikar-Ciglenečki, Maja Rupnik, Stanka Vadnjal, Katja Zelenik, Majda Biasizzo · 2020 · Eurosurveillance
78. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection
    Michael G. Dieterle, Rosemary K.B. Putler, D. Alexander Perry, Anitha Menon, Lisa Abernathy Close, Naomi Perlman, Aline Penkevich, Alexandra K. Standke, Micah Keidan, Kimberly C. Vendrov et al. · 2020 · mBio
79. Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016
    David R. Snydman, Laura A. McDermott, Stephen G. Jenkins, E. J. C. Goldstein, Robin Patel, Betty Ann Forbes, Stuart Johnson, Dale N. Gerding, Cheleste M. Thorpe, Seth T. Walk · 2020 · Anaerobe
80. A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects
    Kevin W. Garey, Khurshida Begum, Chris K. Lancaster, Anne J Gonzales-Luna, Dinh Bui, Julie Mercier, Corinne Seng Yue, Murray P. Ducharme, Ming Hu, Bradley D. Vince et al. · 2020 · Journal of Antimicrobial Chemotherapy
81. Pre-Trained Deep Convolutional Neural Network for Clostridioides Difficile Bacteria Cytotoxicity Classification Based on Fluorescence Images
    Andrzej Brodzicki, Joanna Jaworek-Korjakowska, Paweł Kłeczek, Megan Garland, Matthew S. Bogyo · 2020 · Sensors
82. Systematic Review: Study of the Prescribing Pattern of Antibiotics in Outpatients and Emergency Departments in the Gulf Region
    Rana Kamran Mahmood, Syed Wasif Gillani, Muhammad Waqas Saeed, Muhammad Umar Hafeez, Shabaz Mohiuddin Gulam · 2020 · Frontiers in Pharmacology
83. The high prevalence of Clostridioides difficile among nursing home elders associates with a dysbiotic microbiome
    John Patrick Haran, Doyle V. Ward, Shakti K. Bhattarai, Ethan B Loew, Protiva Dutta, Amanda Higgins, Beth A. McCormick, Vanni Bucci · 2021 · Gut Microbes
84. Prevalence and impact of Clostridioides difficile infection among hospitalized patients with coranavirus disease 201 9
    Jessica Ravikoff Allegretti, Cheikh Nije, Emma L. McClure, Walker D. Redd, Danny Wong, Joyce Zhou, Ahmad Najdat Bazarbashi, Thomas R. McCarty, Kelly Hathorn, Lin Shen et al. · 2021 · JGH Open
85. A cortex-specific penicillin-binding protein contributes to heat resistance in Clostridioides difficile spores
    Yasir Adil Jabbar Alabdali, Peter Oatley, Joseph A. Kirk, Robert P. Fagan · 2021 · Anaerobe
86. “Bacterial Consortium”: A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
    Gianluca Quaranta, Gianluca Ianiro, Flavio De Maio, Alessandra Guarnaccia, Giovanni Fancello, Chiara Agrillo, Federica Iannarelli, Stefano Bibbò, Amedeo Amedei, Maurizio Sanguinetti et al. · 2022 · BioMed Research International
87. Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile
    Qiwen Dong, Huaiying Lin, Marie-Maude Allen, Julian R. Garneau, Jonathan Kevin Sia, Rita C. Smith, Fidel Haro, Tracy A. McMillen, Rosemary L. Pope, Carolyn K. Metcalfe et al. · 2023 · Cell Reports
88. A Call for Greater Consideration for the Role of Vaccines in National Strategies to Combat Antibiotic-Resistant Bacteria: Recommendations from the National Vaccine Advisory Committee
    Walter Albert Orenstein, Bruce G. Gellin, Richard H. Beigi, Sarah Despres, Ruth Lynfield, Yvonne Maldonado, Charles P. Mouton, Wayne S. Rawlins, Mitchel C. Rothholz, Nathaniel Smith et al. · 2016 · Public Health Reports
89. Rapid detection of Clostridium difficile toxins and laboratory diagnosis of Clostridium difficile infections
    Shuyi Chen, Huawei Gu, Chunli Sun, Haiying Wang, Jufang Wang · 2016 · Infection
90. Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa
    Brian Kullin, Justyna Wojno, Valerie R. Abratt, S. J. Reid · 2016 · European Journal of Clinical Microbiology & Infectious Diseases
91. Gut microbiota and Clostridium difficile infections
    Jean‐Christophe Lagier · 2016 · Human Microbiome Journal
92. Clostridium difficile colonization and infection in patients with hepatic cirrhosis
    Yan Dong, Yunbo Chen, Tao� Lv, Yandi Huang, Jiezuan Yang, Yongtao Li, Jianrong Huang, Lanjuan Li · 2017 · Journal of Medical Microbiology
93. Clostridium difficile in Inflammatory Bowel Disease: A Retrospective Study
    William Gillespie, Neil B. Marya, Julien Fahed, Gregory J. Leslie, Krunal Patel, David R. Cave · 2017 · Gastroenterology Research and Practice
94. Differential requirements for conserved peptidoglycan remodeling enzymes during Clostridioides difficile spore formation
    John W. Ribis, Kelly A. Fimlaid, Aimee Shen · 2018 · Molecular Microbiology
95. Risk factors and outcomes of Clostridium difficile infection in hospitalized patients
    Hao-Yuan Lee, Hsuan-Ling Hsiao, Chin‐Yuan Chia, Chun-Wen Cheng, Tzu‐Cheng Tsai, Shin‐Tarng Deng, Chyi‐Liang Chen, Cheng‐Hsun Chiu · 2019 · Biomedical Journal
96. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates
    Laura Tijerina-Rodríguez, Licet Villarreal-Treviño, Simon D. Baines, Rayo Morfín‐Otero, Adrián Camacho-Ortíz, Samantha Flores-Treviño, Héctor Jesús Maldonado-Garza, Eduardo Rodríguez-Noriega, Elvira Garza‐González · 2019 · PLoS ONE
97. Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Clostridioides difficile Infection
    Alessandra Oliva, Lucia Aversano, Massimiliano De Angelis, Maria Teresa Mascellino, Maria Claudia Miele, Sergio Morelli, Riccardo Battaglia, Jessica Iera, Giovanni Bruno, Enrico Stefano Corazziari et al. · 2019 · Open Forum Infectious Diseases
98. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
    Raseen Tariq, Srishti Saha, Dipesh Solanky, Darrell S. Pardi, Sahil Khanna · 2020 · Journal of Clinical Gastroenterology
99. Clostridioides difficile specific DNA adenine methyltransferase CamA squeezes and flips adenine out of DNA helix
    Jujun Zhou, John R. Horton, Robert Blumenthal, Xing Zhang, Xiaodong Cheng · 2021 · Nature Communications
100. The global burden and trend of Clostridioides difficile and its association with world antibiotic consumption, 1990–2019
     Yonghao Chen, Xiaoxi Xie, Qintao Ge, Xiaogang He, Zhiyuan Sun, Yanni Li, Yaoyu Guo, Chong Geng, Xiao Li, Chunhui Wang · 2024 · Journal of Global Health